Bronchiolitis

Progress in Respiratory Research

Volumn 36, Issue , 2007, Pages 292-306

  Poletti, V ^a,b   Casoni, G ^a   Zompatori, M ^c   Chilosi, M ^d  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49449100143     PISSN: 14222140     EISSN: 16623932     Source Type: Book Series    
DOI: 10.1159/000102699     Document Type: Review

References (33)

1. Colby TV: Bronchiolitis: pathologic considerations. Am J Clin Pathol 1998;109:101.
2. Poletti V, Chilosi M, Zompatori M: Bronchiolitis; in Gibson GJ, Geddes DM, Costabel U, Sterk PJ, Corrin B (eds): Respiratory Medicine. Philadelphia, Saunders, 2003, vol 2, pp 1526-1539.
3. Poletti V, Casoni G, Chilosi M, Zompatori M: Diffuse panbronchiolitis. Eur Respir J 2006;28:862-871.
4. Aguayo SM, Miller YE, Waldron JA, et al: Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992;327:1285.
5. Thurlbeck WM, Write JL: Chronic airflow obstruction; in: Thurlbeck's Chronic Airflow Obstruction, ed 2. New York, Decker, 1999.
6. Chen X: The p53 family: same response, different signals? Mol Med Today 1999;5:387.
7. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305.
8. Elssner A, Jaumann F, Dobmann S, Behr J, Schwaiblmair M, Reichenspurner H, Furst H, Briegel J, Vogelmeier C: Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Transplantation 2000;70:362.
9. Belperio JA, Keane P, Burdick MD, Lynch JP, Xue Y, Li K, Ross DJ, Strieter RM: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002;169:1037-1049.
10. Belperio JA, Keane MP, Burdick MD, Gomperts B, Xue Y, Hong K, Mestas J, Ardehali A, Mehrad B, Saggar R, Lynch JP, Ross DJ, Strieter RM: Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest 2005;115:1150-1162.
11. Kim CK, Kim SW, Kim YK, Kang H, Yu J, Yoo Y, Koh YY: Bronchoalveolar lavage eosinophil cationic protein and interleukin-8 levels in acute asthma and acute bronchiolitis. Clin Exp Allergy 2005;35:591-597.
12. Pipavath SJ, Lynch DA, Cool C, Brown KK, Newell JD: Radiologic and pathologic features of bronchiolitis. Am J Roentgenol 2005;185:354-363.
13. Ward C, De Soyza A, Fisher AJ, Pritchard G, Forrest I, Corris P: A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients. J Heart Lung Transplant 2005;24:533-537.
14. Siddiqui MT, Garrity ER, Martinez R, Husain AN: Bronchiolar basement membrane changes associated with bronchiolitis obliterans in lung allografts: a retrospective study ofserial transbronchial biopsies with immunohistochemistry. Mod Pathol 1996;9:320-328.
15. Brugiere O, Thabut G, Mal H, Marceau A, Dauriat G, Marrash-Chahla R, Castier Y, Leseche G, Colombat M, Fournier M: Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome. Eur Respir J 2005;25:813-819.
16. Ghanei M, Moqadam FA, Mohammad MM, Alani J: Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med 2006;173:304-309.
17. Oonakahara K, Matsuyama W, Higashimoto I, Machida K, Kawabata M, Arimura K, Osame M, Hayashi M, Ogura T, Imaizumi K, Hasegawa Y: Outbreak of Bronchiolitis obliterans associated with consumption of Sauropus androgynus in Japan: alert of food-associated pulmonary disorders from Japan. Respiration 2005;72:221.
18. Cortot AB, Cottin V, Miossec P, Fauchon E, Thivolet-Bejui F, Cordier JF: Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept. Respir Med 2005;99:511-514.
19. Mattsson J, Remberger M, Andersson O, Sundberg B, Nord M: Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation. Transplantation 2005;79:1411-1416.
20. Konen E, Gutierrez C, Chaparro C, Murray CP, Chung T, Crossin J, Hutcheon MA, Paul NS, Weisbrod GL: Bronchiolitis obliterans syndrome in lung transplant recipients: can thin-section CT findings predict disease before its clinical appearance? Radiology 2004;231:467-473.
21. Yates B, Murphy DM, Forrest IA, Ward C, Rutherford RM, Fisher AM, Lordan JL, Dark JH, Corris PA: Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005;2:772-775.
22. Khalid M, Al Saghir A, Saleemi S, Al Dammas S, Zeitouni M, Al Mobeireek A, Chaudhry N, Sahovic E: Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 2005;25:490-493.
23. Miller RR, Muller NL: Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 1995;19:653.
24. Cohen AJ, King TE, Gilman LB, Magill-Solc C, Miller YE: High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells. Am J Respir Crit Care Med 1998;158:1593-1599.
25. Keicho N, Totunaga K, Nakata K, et al: Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med 1998;158:846.
26. Turton CW, Williams G, Green M: Cryptogenic obliterative bronchiolitis in adults. Thorax 1981;36:805.
27. Kraft M, Mortensen RL, Colby TV, Newman L, Waldron JA, King TE: Cryptogenic constrictive bronchiolitis: a clinicopathologic study. Am Rev Respir Dis 1992;148:1093.
28. Fukuoka J, Franks T, Colby TV, Flaherty KR, Galvin JR, Hayden DD, Gochuico BR, Kazerooni EA, Martinez F, Travis WD: Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am J Surg Pathol 2005;29:948-954.
29. Myers JL, Veal CF, Shin MS, Katzenstein AL: Respiratory bronchiolitis causing interstitial lung disease. Am Rev Respir Dis 1987;135:880.
30. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz MI, Mallory GB, Snell GI, Yousem S: Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
31. Eschenbacher WL, Kreiss K, Lougheed MD, Pransky GS, Day B, Castellan RM: Nylon flock-associated interstitial lung disease. Am J Respir Crit Care Med 1999;159:2003-2008.
32. Kindt GC, Weiland JE, Davis WB, Gadek JE, Dorinsky PM: Bronchiolitis in adults. A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989;140:483-492.
33. Colby TV, Camus P: Pathology of pulmonary involvement in inflammatory bowel disease. Eur Respir Mon 2007;39:199-207.